Skip to main content
. 2016 Sep 1;7(39):64100–64108. doi: 10.18632/oncotarget.11799

Figure 4. Effects of miR-19b on the proliferation, migration and apoptosis of MCF-7 and MDA-231 cells.

Figure 4

(A) Cell viability assays were performed 12, 24, 36 and 48 h after the transfection of MCF-7 and MDA-231 cells with pre-miR-control, pre- miR- 19b, anti-miR-control or anti-miR-19b. (B and C) Transwell migration assays were performed after the transfection of MCF-7 and MDA-231 cells with pre-miR-control, pre-miR-19b, anti-miR-control or anti-miR-19b. (D and E) Apoptosis assays were performed after the transfection of MCF-7 and MDA-231 cells with pre-miR-control, pre-miR-19b, anti-miR-control or anti-miR-19b. ***P < 0.001; **P < 0.01; *P < 0.05.